Fuller; Peter H.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Fuller; Peter H..The latest application filed is for "1-pyrazolyl, 5-, 6- disubstituted indazole derivatives as lrrk2 inhibitors, pharmaceutical compositions, and uses thereof".

Company Profile

9.10.11

Fuller; Peter H. - Ashland MA
Fuller; Peter H. - Boston MA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
1-pyrazolyl, 5-, 6- Disubstituted Indazole Derivatives As Lrrk2 Inhibitors, Pharmaceutical Compositions, And Uses Thereof App 20220259188 - Zhou; Hua ; et al.	2022-08-18
N-heteroaryl Indazole Derivatives As Lrrk2 Inhibitors, Pharmaceutical Compositions, And Uses Thereof App 20210395236 - SIMOV; Vladimir ; et al.	2021-12-23
Indazolyl-spiro[2.3]hexane-carbonitrile derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereof Grant 11,174,248 - Acton , et al. November 16, 2	2021-11-16
Indazolyl-spiro[2.2]pentane-carbonitrile derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereof Grant 11,161,854 - Candito , et al. November 2, 2	2021-11-02
Indazolyl-spiro[2.3]hexane-carbonitrile Derivatives As Lrrk2 Inhibitors, Pharmaceutical Compositions, And Uses Thereof App 20210188818 - Acton; John ; et al.	2021-06-24
Indazolyl-spiro[2.2]pentane-carbonitrile Derivatives As Lrrk2 Inhibitors, Pharmaceutical Compositions, And Uses Thereof App 20210188863 - Candito; David Annunziato ; et al.	2021-06-24
Aminopyrazoles as selective janus kinase inhibitors Grant 10,875,847 - Fuller , et al. December 29, 2	2020-12-29
Substituted indazole compounds as RORgammaT inhibitors and uses thereof Grant 10,689,369 - Lapointe , et al.	2020-06-23
Aminopyrazoles as Selective Janus Kinase Inhibitors App 20200115367 - Fuller; Peter H. ; et al.	2020-04-16
Tricyclic compounds as inhibitors of mutant IDH enzymes Grant 10,442,819 - Fischer , et al. Oc	2019-10-15
SUBSTITUTED INDAZOLE COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF App 20190276438 - Lapointe; Blair T. ; et al.	2019-09-12
Substituted bicyclic pyrazole compounds as RORgammaT inhibitors and uses thereof Grant 10,344,000 - Lapointe , et al. July 9, 2	2019-07-09
Substituted indazole compounds as RORgammaT inhibitors and uses thereof Grant 10,287,272 - Lapointe , et al.	2019-05-14
Substituted pyrazole compounds as RORgammaT inhibitors and uses thereof Grant 10,221,142 - Lapointe , et al.	2019-03-05
SUBSTITUTED INDAZOLE COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF App 20180312489 - Lapointe; Blair T. ; et al.	2018-11-01
SUBSTITUTED BICYCLIC PYRAZOLE COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF App 20180305320 - Lapointe; Blair T. ; et al.	2018-10-25
SUBSTITUTED PYRAZOLE COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF App 20180016239 - Lapointe; Blair T. ; et al.	2018-01-18

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.